Prof. Dr. Sema Sezgin Goksu
Timeline
Career milestones.
Scientific work
Selected peer-reviewed publications.
-
2024New England Journal of Medicine«Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer»· co-author
-
2024Scientific Reports«Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases»· co-author
-
2022Cancer Investigation«Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer»· co-author
-
2021Cancer Chemotherapy and Pharmacology«Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck»· first author
Where they practise
Direct contract with BergemHealth at every listed clinic.
Tell me about your case — I’ll read it personally.
Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.
Open the consultation form- Reply within 4 hours during business hours
- Confidentiality guaranteed
- Coordinator-translator inside the doctor’s office
- Tumour board of 2–3 professors within 72 hours
Similar BergemHealth professors
Adjacent specialties and second opinions. Direct contracts, verified cases.